Simultaneous high expression of PLD1 and Sp1 predicts a poor prognosis for pancreatic ductal adenocarcinoma patients

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with few therapeutic options. Recently, insight into cancer biology suggested abnormal lipid metabolism to be a risk factor for human malignancies. As a key enzyme implicated in lipid metabolism, PLD1 was elevated in various human cancer as...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Jiong, Hu, Hai, Hang, Jun-jie, Yang, Hai-yan, Wang, Zhi-yong, Wang, Lei, Chen, Dong-hui, Wang, Li-wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346659/
https://www.ncbi.nlm.nih.gov/pubmed/27713167
http://dx.doi.org/10.18632/oncotarget.12447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346659/
https://www.ncbi.nlm.nih.gov/pubmed/27713167
http://dx.doi.org/10.18632/oncotarget.12447

Ejemplares similares